-
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
-
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

